HF
IDXX icon

Hoxton Financial’s Idexx Laboratories IDXX Stock Holding History

Hoxton Financial’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-852
Closed -$42K – 710
2013
Q3 		$42K Sell
852
-42
-5% -$2.02K 0.04% 138
2013
Q2 		$40K Buy
+894
New +$39.1K 0.02% 218

Other funds holding IDXX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.43B AUM 18.44% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Hoxton Financial's IDXX Position: Q4 2013 in Review

Hoxton Financial sold out of Idexx Laboratories (IDXX) in Q4 2013, closing a stake of 852 shares — an estimated $42K sold.

Hoxton Financial first reported a position in IDXX in Q2 2013 and held it in 2 quarters. The position peaked at $42K in Q3 2013. 298 funds tracked by Wall St. Rank hold IDXX as of Q4 2013.

  • Hoxton Financial reported no remaining Idexx Laboratories position as of Q4 2013 after selling out during the quarter.
  • Hoxton Financial sold 852 Idexx Laboratories shares in Q4 2013, an estimated $42K.
  • Hoxton Financial first reported a position in Idexx Laboratories in Q2 2013 and held it in 2 quarters.
  • Hoxton Financial's Idexx Laboratories position peaked at $42K in Q3 2013.
  • 298 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2013.

Based on Hoxton Financial's 13F filing for Q4 2013, filed 16 Jan 2014.